Articles
Evaluation of the Effect of Heart Failure Reversal Therapy on Exercise Capacity in Patients with Chronic Heart Failure and the Association with Co-morbidities
Citation:
European Cardiology Review 2020;15:e39.
- Downloads:
7
Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction
Citation:
European Cardiology Review 2020;15:e32.
- Downloads:
14
Prescription of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction Attending an Outpatient Heart Failure Clinic
Citation:
European Cardiology Review 2020;15:e31.
- Downloads:
16
Relationship Between VEGF-C Levels and All-cause Mortality in Patients with Chronic Heart Failure
Citation:
European Cardiology Review 2018;13(2):129.
- Downloads:
0
The Mechanism of Hey2 Expression in Cardiac Development
Citation:
European Cardiology Review 2018;13(2):128.
- Downloads:
0
The Role of p53 Localised in Cytosol and Mitochondria During Reprogramming to iPS Cells
Citation:
European Cardiology Review 2018;13(2):127.
- Downloads:
1
A PRMT5 Selective Inhibitor EPZ015666 Suppressed TAC-induced Left Ventricular Dysfunction
Citation:
European Cardiology Review 2018;13(2):130.
- Downloads:
0
TBL1 Suppresses Cardiomyocyte Hypertrophy by Regulating the Interaction Between HDAC3 and GATA4
Citation:
European Cardiology Review 2018;13(2):126.
- Downloads:
1
The GATA4 Acetylation Site Plays a Key Role in the Development of Cardiomyocyte Hypertrophy
Citation:
European Cardiology Review 2018;13(2):125.
- Downloads:
1